Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.04 CAD | -0.20% | -4.38% | -9.55% |
Sales 2024 * | 15.95M 11.67M | Sales 2025 * | 43.69M 31.96M | Capitalization | 245M 179M |
---|---|---|---|---|---|
Net income 2024 * | -38M -27.79M | Net income 2025 * | -30M -21.94M | EV / Sales 2024 * | 14.5 x |
Net cash position 2024 * | 13.74M 10.05M | Net Debt 2025 * | 41.34M 30.23M | EV / Sales 2025 * | 6.56 x |
P/E ratio 2024 * |
-6.44
x | P/E ratio 2025 * |
-7.15
x | Employees | 131 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.29% |
Latest transcript on Profound Medical Corp.
1 day | -0.20% | ||
1 week | -4.38% | ||
Current month | -3.46% | ||
1 month | -8.64% | ||
3 months | -11.93% | ||
6 months | -23.36% | ||
Current year | -9.55% |
Managers | Title | Age | Since |
---|---|---|---|
Arun Menawat
CEO | Chief Executive Officer | 69 | 15-06-03 |
Rashed Dewan
DFI | Director of Finance/CFO | 56 | 15-06-30 |
Mathieu Burtnyk
COO | Chief Operating Officer | 42 | 11-07-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arthur Rosenthal
BRD | Director/Board Member | 77 | 18-06-13 |
Director/Board Member | 67 | 18-06-13 | |
Cynthia Lavoie
BRD | Director/Board Member | - | 21-03-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 10.04 | -0.20% | 1,109 |
24-05-03 | 10.06 | +0.50% | 1,000 |
24-05-02 | 10.01 | -0.40% | 3,900 |
24-05-01 | 10.05 | -3.37% | 2,001 |
24-04-30 | 10.4 | -0.95% | 2,900 |
Delayed Quote Toronto S.E., May 06, 2024 at 03:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.55% | 180M | |
+8.06% | 218B | |
+6.94% | 184B | |
+13.54% | 135B | |
-0.27% | 62.38B | |
+11.59% | 51.37B | |
+7.76% | 50.9B | |
+1.14% | 40.87B | |
+3.21% | 36.28B | |
+26.11% | 31.88B |
- Stock Market
- Equities
- PRN Stock